Age | Age at diagnosis | Age at ILD diagnosis | FVC at ILD diagnosis (%) | DLCO at ILD diagnosis (%) | FVC post CyC (%) | DLCO post CyC (%) | FVC post RTX (%) | DLCO post RTX (%) | Cumulative CyC dose (g) | |
---|---|---|---|---|---|---|---|---|---|---|
Patient 1 | 51 | 31 | 39 | 53 | 80 | 40 | 28.9 | 51.4 | 31.4 | 21 |
Patient 2 | 35 | 28 | 28 | 47.8 | 38 | 38.6 | 16 | 37.5 | 15.7 | 20 |
Patient 3 | 65 | 58 | 58 | 49.8 | 40.8 | 37.9 | 30.7 | 15 | ||
Patient 4 | 52 | 47 | 47 | 62 | 55 | 56 | 45 | 60 | 61 | 27 |
Mean ± SD | 50.75±12.28 | 39±13.49 | 43±12.65 | 53.15±6.28 | 53.45±19.2 | 44.87±9.67 | 29.97±14.53 | 44.9±13.25 | 36.03±23 | 20.43±5.23 |